Homepage
Faculty Member Receives Prestigious Promotion to Associate Professor
Zhiqiang Lin, Ph.D., has been promoted to associate professor of biomedical research and translational medicine at the MMRI, recognizing his significant contributions since joining the organization in 2018. Lin has been instrumental in advancing cardiovascular research as a key faculty member at MMRI. Lin earned his Ph.D. from Peking University in 2008, followed by postdoctoral…
Read MoreMMRI awarded $200,000 by Lupus and Allied Diseases Association
On Thursday, August 14, 2024, officials from MMRI received a surprise announcement by LADA President and CEO, Kathleen Arntsen, that its three previously supported SLE research projects would receive an additional $50,000 each this year, and for one new project focused on lupus nephritis, which received an additional $50,000, totaling $200,000. The check was presented…
Read MoreMMRI Held Graduation Ceremony for Largest Summer Fellowship Cohort To-Date
On Friday, July 26, 2024, MMRI held its annual graduation ceremony to honor the accomplishments of its 19 Summer Fellows who completed the esteemed scientific program. For ten weeks, these Summer Fellows studied under MMRI’s principal investigators (PI) gaining invaluable scientific research experience, as well as with administrative executives, gaining insights into MMRI’s operational endeavors.…
Read MoreAmerica Heart Association invests in the future at Masonic Medical Research Institute
11.29.2023 Cardiovascular research is going strong at Masonic Medical Research Institute (MMRI), where four scientists currently have projects funded by the American Heart Association for a total amount of $499,000. Read The Sentinel’s article here. Watch WKTV’s story here. Read WIBX’s article here. Read the Utica Chamber of Commerce article here.
Read MoreMeet MMRI: Tongbin Wu Ph.D.
Tongbin Wu, Ph.D., has been named assistant professor of biomedical research and translational medicine at MMRI. In this role, Wu will oversee a laboratory dedicated to heart development and cardiovascular medicine. Specifically, his laboratory will research novel therapeutic targets and advance the development of treatments for left ventricular noncompaction (LVNC), a cardiac muscle disorder in…
Read More